Back to OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

All insider transactions

4 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 23, 2026SellClass A Common StockLeverone Jason A.
Executive
-301$4.16$1.3K16,000low
Mar 23, 2026SellClass A Common StockSaccomano Nicholas A
CEO
-86$4.16$3577,333low
Dec 31, 2025Other
Grant / award
Class A Common StockManke Isaac
Director
+5,258$0.00$020,583low
Dec 31, 2025Other
Grant / award
Class A Common StockMathers Edward T
Director
+3,911$0.00$015,310low
← PrevPage 1 of 1Next →